Get startedLog in
    Picture of Quest PharmaTech logo

    QPT — Quest PharmaTech News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Oncoquest Announces Publication Of Two Reports Related To Oregovomab Phase 2 Clinical Trial

    Picture of Quest PharmaTech logoQuest PharmaTech
    24/03/2020 12:10
    March 24 (Reuters) - Quest Pharmatech Inc  QPT.V :
    * ONCOQUEST ANNOUNCES PUBLICATION OF TWO REPORTS RELATED TO
OREGOVOMAB PHASE 2 CLINICAL TRIAL, THE COMPANY'S LEAD
INVESTIGATIONAL DRUG IN FRONTLINE OVARIAN CANCER
    * QUEST PHARMATECH INC - CURRENTLY PLANNING TO LAUNCH A
PHASE 3
TRIAL IN Q2 2020.

Source text for Eikon:  ID:nCNWZtqjfa 
Further company coverage:  QPT.V 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Quest PharmaTech

    See all news